Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner.
Prions or PrP(Sc) are proteinaceous infectious agents that consist of misfolded, self-replicating states of the prion protein or PrP(C) PrP(C) is posttranslationally modified with N-linked glycans and a sialylated glycosylphosphatidylinositol (GPI) anchor. Conformational conversion of PrP(C) gives rise to glycosylated and GPI-anchored PrP(Sc) The question of the sialylation status of GPIs within PrP(Sc) has been controversial. Previous studies that examined scrapie brains reported that both sialo- and asialo-GPIs were present in PrP(Sc), with the majority being asialo-GPIs. In contrast, recent work that employed cultured cells claimed that only PrP(C) with sialylo-GPIs could be recruited into PrP(Sc), whereas PrP(C) with asialo-GPIs inhibited conversion. To resolve this controversy, we analyzed the sialylation status of GPIs within PrP(Sc) generated in the brain, spleen, or cultured N2a or C2C12 myotube cells. We found that recruiting PrP(C) with both sialo- and asialo-GPIs is a common feature of PrP(Sc) The mixtures of sialo- and asialo-GPIs were observed in PrP(Sc) universally regardless of prion strain as well as host, tissue, or type of cells that produced PrP(Sc) Remarkably, the proportion of sialo- versus asialo-GPIs was found to be controlled by host, tissue, and cell type but not prion strain. In summary, this study found no strain-specific preferences for selecting PrP(C) with sialo- versus asialo-GPIs. Instead, this work suggests that the sialylation status of GPIs within PrP(Sc) is regulated in a cell-, tissue-, or host-specific manner and is likely to be determined by the specifics of GPI biosynthesis.
From the Center for Biomedical Engineering and Technology and the Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Elizaveta
E
Katorcha
From the Center for Biomedical Engineering and Technology and the Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Saurabh
S
Srivastava
From the Center for Biomedical Engineering and Technology and the Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201.
Nina
N
Klimova
From the Center for Biomedical Engineering and Technology and the Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland 21201 baskakov@umaryland.edu.
Ilia V
IV
Baskakov
D000818:Animals; D002460:Cell Line; D006031:Glycosylation; D051379:Mice; D009844:Oligosaccharides / Q000235:genetics / Q000378:metabolism*; D009928:Organ Specificity / Q000235:genetics; D018620:PrPSc Proteins / Q000235:genetics / Q000378:metabolism*; D012608:Scrapie / Q000235:genetics / Q000378:metabolism*
C559297:(6-O-aminoethylphosphonato-mannopyranosyl)-(1-2)-mannopyranosyl-(1-6)-mannopyranosyl-(1-4)-(2-amino-2-deoxyglucopyranosyl)-(1-6)-1-O-(1,2-di-O-octadecanoyl-sn-glyceryl-phosphonato)-myo-inositol; D009844:Oligosaccharides; D018620:PrPSc Proteins
brain; glycosylphosphatidylinositol (GPI anchor); myotube; prion; prion disease; sialic acid; sialylation; spleen